Healthcare
BioNTech’s Bet on BNT323 Intensifies as Restructuring and Pipeline Data Pave Way for Regulatory Milestone
The next few months will decide whether BioNTech can turn its sprawling oncology pipeline into a revenue-generating reality. With a...
Eli Lilly’s Most Consequential Weekend: New Mounjaro Data Meets a $3.8 Billion Vaccine Pivot
Eli Lilly closed last week with a flurry of news that turned the stock into a tale of two catalysts....
Eli Lilly’s Two-Front Victory: A Trillion-Dollar Valuation and a Pharmacy Benefit Win Reshape the Obesity Landscape
Eli Lilly has barrelled past a historic threshold, becoming the first pharmaceutical company to reach a market capitalisation of $1...
Siemens Healthineers Shares Test Support After China Diagnostics Hit Sinks Earnings and Guidance
The structural breakdown in China’s diagnostics market has sent Siemens Healthineers shares spiralling to their weakest level in a year,...
BioNTech’s $650 Million R&D Quarter: Shareholders Back Board Expansion as Market Awaits Lung Cancer Data
Despite sitting on nearly $20 billion in cash, BioNTech is burning through money at an accelerating pace as it races...
Ocugen’s Gene Therapy Candidates Race Toward FDA Filings, But the Market Isn’t Ready to Celebrate
Ocugen is making quiet but meaningful progress across its pipeline of gene therapy programmes, yet the stock tells a more...
Ocugen Locks In Cash Runway to 2028 as Gene Therapy Platform Heads to Fort Lauderdale and Beyond
Ocugen has closed a $115 million convertible note offering that buys the biotech group more than two years of operating...
Novo Nordisk’s Teen Pill Win Offers a Rebound, But the Washington Game Is Shifting
Novo Nordisk’s shares staged a dramatic recovery on Friday, surging nearly 7% to close at €35.16, as investors seized on...
Siemens Healthineers Faces a Perfect Storm as Basel Conference Opens Against a Backdrop of Debt and Declining Shares
The irony could hardly be starker. As Siemens Healthineers kicks off the ECIO oncology conference in Basel today, showcasing the...
BioNTech’s COO Cashes Out $5.5 Million Just as Cancer Pipeline Momentum Builds
The rally in BioNTech shares this month has been one of the sector's standout stories, but a hefty insider sale...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
